This company has been marked as potentially delisted and may not be actively trading. (TMH) (TMH) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrendsBuy This Stock TMH vs. LH, DGX, DVA, CHE, CRVL, AMED, MD, AMN, and CCRNShould you be buying (TMH) stock or one of its competitors? The main competitors of (TMH) include Labcorp (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), and Cross Country Healthcare (CCRN). These companies are all part of the "health care services" industry. (TMH) vs. Its Competitors Labcorp Quest Diagnostics DaVita Chemed CorVel Amedisys Pediatrix Medical Group AMN Healthcare Services Cross Country Healthcare Labcorp (NYSE:LH) and (TMH) (NYSE:TMH) are both health care services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability, media sentiment and dividends. Do analysts rate LH or TMH? Labcorp currently has a consensus target price of $289.58, indicating a potential upside of 6.74%. Given Labcorp's stronger consensus rating and higher probable upside, equities analysts clearly believe Labcorp is more favorable than (TMH).Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Labcorp 1 Sell rating(s) 3 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.62(TMH) 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders believe in LH or TMH? 95.9% of Labcorp shares are owned by institutional investors. 0.8% of Labcorp shares are owned by insiders. Comparatively, 1.3% of (TMH) shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media prefer LH or TMH? In the previous week, Labcorp had 21 more articles in the media than (TMH). MarketBeat recorded 21 mentions for Labcorp and 0 mentions for (TMH). Labcorp's average media sentiment score of 1.39 beat (TMH)'s score of 0.00 indicating that Labcorp is being referred to more favorably in the media. Company Overall Sentiment Labcorp Positive (TMH) Neutral Is LH or TMH more profitable? Labcorp has a net margin of 5.66% compared to (TMH)'s net margin of 0.00%. Labcorp's return on equity of 15.45% beat (TMH)'s return on equity.Company Net Margins Return on Equity Return on Assets Labcorp5.66% 15.45% 7.02% (TMH) N/A N/A N/A Which has stronger earnings & valuation, LH or TMH? Labcorp has higher revenue and earnings than (TMH). CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLabcorp$13.01B1.73$746M$9.0629.94(TMH)N/AN/AN/AN/AN/A SummaryLabcorp beats (TMH) on 10 of the 11 factors compared between the two stocks. Get (TMH) News Delivered to You Automatically Sign up to receive the latest news and ratings for TMH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TMH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMH vs. The Competition Export to ExcelMetric(TMH) Industry SectorNYSE ExchangeMarket CapN/A$2.07B$2.08B$21.05BDividend YieldN/A13.71%13.69%3.56%P/E RatioN/A12.4912.2828.03Price / SalesN/A2,775,427.652,996,405.3757.07Price / CashN/A19.3557.5323.95Price / BookN/A3.253.095.26Net IncomeN/A-$440.16M-$456.46M$994.11M (TMH) Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMH(TMH)N/A$53.090.0%N/AN/A$0.00N/A0.00N/ALHLabcorp4.7535 of 5 stars$261.34+0.5%$289.58+10.8%+21.4%$21.77B$13.01B28.8570,000Positive NewsInsider TradeDGXQuest Diagnostics4.5644 of 5 stars$170.81+2.0%$186.00+8.9%+18.7%$18.72B$9.87B20.4656,000Trending NewsDividend AnnouncementAnalyst RevisionDVADaVita4.3718 of 5 stars$138.44-1.4%$167.40+20.9%-7.7%$10.60B$12.82B13.7276,000News CoverageCHEChemed4.9872 of 5 stars$418.08+1.4%$579.75+38.7%-21.3%$6.03B$2.51B21.5015,695Positive NewsEx-DividendCRVLCorVel1.7341 of 5 stars$86.71-2.1%N/A-11.0%$4.56B$895.59M47.215,075News CoveragePositive NewsAMEDAmedisys2.7573 of 5 stars$98.51-0.1%$100.50+2.0%+3.0%$3.24B$2.35B38.3319,000Short Interest ↑High Trading VolumeMDPediatrix Medical Group1.8796 of 5 stars$11.98-2.2%$16.67+39.1%+53.2%$1.05B$1.98B-11.864,305News CoveragePositive NewsAnalyst ForecastAMNAMN Healthcare Services4.3581 of 5 stars$17.82-2.8%$32.08+80.0%-64.8%$702.15M$2.85B-4.122,968News CoverageEarnings ReportAnalyst ForecastCCRNCross Country Healthcare3.5643 of 5 stars$13.04-3.0%$17.93+37.5%-9.1%$440.93M$1.26B-24.608,205Analyst Revision Related Companies and Tools Related Companies LH Alternatives DGX Alternatives DVA Alternatives CHE Alternatives CRVL Alternatives AMED Alternatives MD Alternatives AMN Alternatives CCRN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:TMH) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (TMH) Please log in to your account or sign up in order to add this asset to your watchlist. Share (TMH) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access